GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeneOne Life Science Inc (XKRX:011000) » Definitions » Construction In Progress

GeneOne Life Science (XKRX:011000) Construction In Progress : ₩0 Mil (As of Mar. 2025)


View and export this data going back to 1987. Start your Free Trial

What is GeneOne Life Science Construction In Progress?

GeneOne Life Science's annual construction in progress declined from Dec. 2022 (₩104,661 Mil) to Dec. 2023 (₩0 Mil) but then stayed the same from Dec. 2023 (₩0 Mil) to Dec. 2024 (₩0 Mil).


GeneOne Life Science Construction In Progress Historical Data

The historical data trend for GeneOne Life Science's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GeneOne Life Science Construction In Progress Chart

GeneOne Life Science Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,489.05 78,282.73 104,660.92 - -

GeneOne Life Science Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

GeneOne Life Science Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


GeneOne Life Science Business Description

Traded in Other Exchanges
N/A
Address
343, Hakdong-ro, Gangnam-Gu, Seoul, KOR
GeneOne Life Science Inc is engaged in the research, development, and manufacturing of biopharmaceutical products including vaccines for treating pandemic influenza, seasonal influenza for old people, and chronic hepatitis B and C as well cancers and other infectious diseases.

GeneOne Life Science Headlines

No Headlines